Minister of Health (Canada)

COP28: Canada Daily Highlights - December 3, 2023

Retrieved on: 
Sunday, December 3, 2023
Ministry, COP26, Woman, Memorandum of understanding, Ecology, Climate change, Minister, Joint, COP28, OECD, Climate, Minister of Health (Canada), Culture, Foreign Affairs, Movement, Indigenous Services Canada, Organization, Least developed countries, Environment, Forestry, Renewable energy, Health

Read more about Canada's announcement of $5 million in climate finance for the Least Developed Countries Initiative for Effective Adaptation and Resilience (LIFE-AR).

Key Points: 
  • Read more about Canada's announcement of $5 million in climate finance for the Least Developed Countries Initiative for Effective Adaptation and Resilience (LIFE-AR).
  • Read the Joint statement from the Minister of Health, the Minister of Environment and Climate Change and the Minister of Indigenous Services on COP28 .
  • Ambassador Catherine Stewart joined her Korean counterpart, Jenny Kim, to announce a Memorandum of Understanding (MoU) between Environment and Climate Change Canada and the Ministry of Foreign Affairs of South Korea.
  • The Minister also met with Teresa Ribera, Spain's Vice-President and Minister for the Ecological Transition on collaborating on nature conservation.

Dr. Edwin Cevallos to give a keynote address on the occasion of High Level week during a side event for the United Nations General Assembly on September 18, 2023, Hosted by the Artemis Aspire Foundation

Retrieved on: 
Thursday, September 14, 2023
Oncology, Health, Infectious Diseases, COVID-19, Radiology, Research, Science, Minister, STEAM, Music, United Nations, Africa Centres for Disease Control and Prevention, Speech, Infection, Caribbean Public Health Agency, Minister of Health (Canada), United Nations General Assembly, Immunotherapy, Dementia, Patient, Immune system, UNGA, Mental health, Medical device, Vaccine, Grammy Awards

The United Nations General Assembly serves as a platform for addressing critical global issues, and this keynote on COVID-19 and the strength of the immune system reflects the ongoing importance of pandemic-related concerns.

Key Points: 
  • The United Nations General Assembly serves as a platform for addressing critical global issues, and this keynote on COVID-19 and the strength of the immune system reflects the ongoing importance of pandemic-related concerns.
  • BIRM - DR. EDWIN CEVALLOS
    The Aspire Artemis Foundation is honored to have Dr. Edwin Cevallos as a featured speaker.
  • "We are delighted to have Dr. Edwin Cevallos as a keynote speaker for Aspire Artemis Foundation’s High Level side event on the occasion of the 78th session of the United Nations General Assembly.
  • For media inquiries, interview requests, or additional information about Dr. Edwin Cevallos' participation in the UNGA event hosted by the Artemis Aspire Foundation, please contact:

Government of Canada Improves Access to Sexual and Reproductive Health Services

Retrieved on: 
Thursday, September 7, 2023
Facts of Life, SERC, Travel, Gender identity, SRH, Education, HIV, Face, AB, Minister of Health (Canada), Woman, Government, Health equity, Organization, Abortion, Risk, ACB, Learning management system, Health Canada, UNAIDS, Indigenous self-government in Canada, Birth control, Prairie, Health

EDMONTON, AB, Sept. 7, 2023 /CNW/ - Everyone, regardless of their sexual or gender identity, should have access to sexual and reproductive health (SRH) services and resources that are safe and stigma-free.

Key Points: 
  • EDMONTON, AB, Sept. 7, 2023 /CNW/ - Everyone, regardless of their sexual or gender identity, should have access to sexual and reproductive health (SRH) services and resources that are safe and stigma-free.
  • "Sexual and reproductive health services are health care.
  • "Everyone has the right to access safe, and stigma-free sexual and reproductive health services.
  • "Health equity outcomes can be improved when people have access to sexual reproductive health information that resonates with their lived experience.

Government of Canada Announces $2.5 million for Projects to Improve Mental Health Supports for Indigenous Peoples

Retrieved on: 
Friday, July 21, 2023
Knowledge, Security Technical Implementation Guide, Partnership, Discrimination, Treasury Board of Canada, The Honourable, Face, Racism, Racism by country, Safety, COVID-19, Treasury Board of Canada Secretariat, Mental health, DSM-IV codes, Minister of Health (Canada), Indigenous peoples, Health system, First Nations, Government, Organization, Dutch Association of Mental Health and Addiction Care, Hope, Mental, Risk, Indigenous peoples in Canada, Indigenous self-government in Canada, Addiction, Health Canada, Woman, Nursing, Pharmaceutical industry, Health

Today, the Honourable Mona Fortier, President of the Treasury Board, on behalf of the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced $2.5 million for two projects led by the First Peoples Wellness Circle (FPWC) that focus on mental health supports for Indigenous Peoples.

Key Points: 
  • Today, the Honourable Mona Fortier, President of the Treasury Board, on behalf of the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced $2.5 million for two projects led by the First Peoples Wellness Circle (FPWC) that focus on mental health supports for Indigenous Peoples.
  • " FPWC will increase the number of mental health professionals in New Brunswick to provide culturally safe and inclusive mental health services and evaluation tools for First Nations populations.
  • "Indigenous Peoples in Canada are at a higher risk of experiencing mental illness, and face unacceptable intersecting barriers in accessing mental health services and supports.
  • The Supporting the Mental Health of Those Most Affected by COVID-19 investment of $100 million was announced in Budget 2021 to support projects that promote mental health and prevent mental illness in populations whose mental health was most affected by COVID-19, including Indigenous Peoples.

Government of Canada Announces $2.5 million for Projects to Improve Mental Health Supports for Indigenous Peoples

Retrieved on: 
Friday, July 21, 2023
Knowledge, Security Technical Implementation Guide, Partnership, Discrimination, Treasury Board of Canada, The Honourable, Face, Racism, Racism by country, Safety, COVID-19, Treasury Board of Canada Secretariat, Mental health, DSM-IV codes, Minister of Health (Canada), Indigenous peoples, Health system, First Nations, Government, Organization, Dutch Association of Mental Health and Addiction Care, Hope, Mental, Risk, Indigenous peoples in Canada, Indigenous self-government in Canada, Addiction, Health Canada, Woman, Nursing, Pharmaceutical industry, Health

Today, the Honourable Mona Fortier, President of the Treasury Board, on behalf of the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced $2.5 million for two projects led by the First Peoples Wellness Circle (FPWC) that focus on mental health supports for Indigenous Peoples.

Key Points: 
  • Today, the Honourable Mona Fortier, President of the Treasury Board, on behalf of the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced $2.5 million for two projects led by the First Peoples Wellness Circle (FPWC) that focus on mental health supports for Indigenous Peoples.
  • "Indigenous Peoples in Canada are at a higher risk of experiencing mental illness, and face unacceptable intersecting barriers in accessing mental health services and supports.
  • "Systemic racism in health care, coupled with the challenges the COVID-19 pandemic brought, has contributed to health disparities, including mental health challenges, among Indigenous Peoples and marginalized populations.
  • The Supporting the Mental Health of Those Most Affected by COVID-19 investment of $100 million was announced in Budget 2021 to support projects that promote mental health and prevent mental illness in populations whose mental health was most affected by COVID-19, including Indigenous Peoples.

ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome

Retrieved on: 
Thursday, June 15, 2023
Central nervous system, Therapy, Special access program, Rett syndrome, Minister of Health (Canada), SAP, Doctor of Philosophy, CNS, DSM-IV codes, Patient, United Kingdom, Diagnosis, Health Canada, Pharmaceutical industry

NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) --  Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that the first patients with Rett syndrome from the ANAVEX®2-73-RS-003 study (EXCELLENCE) are able to continue treatment with ANAVEX®2-73 (blarcamesine) thanks to Health Canada’s approval of the Special Access Program (SAP), allowing for compassionate use following completion of the 48-week Open-Label Extension study.

Key Points: 
  • Special Access Program (SAP) applications are granted at a physicians’ request on behalf of patients.
  • Approved compassionate programs are also ongoing in the United Kingdom and Australia, representing all regions of the Rett Syndrome study participation.
  • “Today there is no specific treatment for Rett syndrome available in Canada and the Ontario Rett Syndrome Association (O.R.S.A.)
  • In compliance with local authorities, many patients from our clinical studies are now able to continue treatment with ANAVEX®2-73 (blarcamesine).”

Syntax launches new Health Practice led by Marjolaine Provost and Dr. Katharine Smart, Past President of the Canadian Medical Association

Retrieved on: 
Monday, December 19, 2022
College, Communication, Liberal, Medicine, Physician, Operation, Woman, Minister of Health (Canada), National & Gulf Center for Evidence Based Health Practice, Canadian Medical Association, Ronald McDonald House Charities, Past, CMA, Dacquoise, Immigration, Marketing, Syntax, Health

The practice will provide clients with full-service support including advocacy and public affairs, strategic communications, media relations, marketing, events and campaigns.

Key Points: 
  • The practice will provide clients with full-service support including advocacy and public affairs, strategic communications, media relations, marketing, events and campaigns.
  • “Our new Health Practice builds on our subject matter expertise and will offer exceptional services to our existing and future clients.
  • The Health Practice will be led by Marjolaine Provost, former Director of Communications for Minister of Health Jean-Yves Duclos, with strategic counsel and guidance from Dr. Katharine Smart, Past President of the Canadian Medical Association.
  • Dr. Smart is the Past President of the Canadian Medical Association (CMA).

Government of Canada announces nearly $10 million to support Indigenous communities address substance-related harms

Retrieved on: 
Friday, December 2, 2022
First Nations, Minister of Health (Canada), Mental health, COVID-19, MTI College, Trauma, Government, Substance, Indigenous self-government in Canada, Community, Harm reduction, Child, Health Canada, Colonialism, Investment, Partnership, Dutch Association of Mental Health and Addiction Care, Indigenous peoples, Drug, City, Organization, Addiction, Renewable energy, Pharmaceutical industry, Whaling, Medicine, Health

The Government of Canada is committed to addressing these harms and connecting all Indigenous communities with the targeted, trauma informed, and culturally safe mental health and substance use supports they need.

Key Points: 
  • The Government of Canada is committed to addressing these harms and connecting all Indigenous communities with the targeted, trauma informed, and culturally safe mental health and substance use supports they need.
  • "Indigenous Peoples carry a disproportionate burden of the harms related to the overdose and toxic illegal drug crisis.
  • The Government of Canada has made significant recent investments to improve mental wellness in Indigenous communities, with an approximate investment of $645 million in 2021-22.
  • Budget 2022 announced $100 million over three years to support harm reduction, treatment, and prevention at the community level.

MITSUBISHI TANABE PHARMA CANADA ANNOUNCES CANADIAN AUTHORIZATION OF RADICAVA® (EDARAVONE) ORAL SUSPENSION FOR THE TREATMENT OF PATIENTS WITH ALS

Retrieved on: 
Wednesday, November 9, 2022
News, Minister of Health (Canada), National Institute of Neurological Disorders and Stroke, Brain, Mitsubishi Tanabe Pharma, MTPA, National, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Amyotrophic lateral sclerosis, National Institutes of Health, Benchmark (surveying), Benchmarking, ALS Society of Canada, Society, NOC, Stroke, Edaravone, Amyotrophy, Geng Shuang, FDA, Diagnosis, Federation, Time, CEO, Food, IV, Safety, Physician, Montreal Neurological Institute and Hospital, Care, Patient, ALS, National Institute, Health Canada, The Lancet, Neurodegeneration, Priority review, Pharmaceutical industry, Medical device, Generic drug, Fine chemical

Today, we are excited to be able to provide patients and physicians with RADICAVA Oral Suspension, an oral formulation of edaravone," says Atsushi Fujimoto, President, MTP-CA.

Key Points: 
  • Today, we are excited to be able to provide patients and physicians with RADICAVA Oral Suspension, an oral formulation of edaravone," says Atsushi Fujimoto, President, MTP-CA.
  • The Health Canada authorization of RADICAVA Oral Suspension is supported by several studies, including data from the pivotal Phase 3 clinical trial (MCI186-19) evaluating 137 ALS patients.
  • About Mitsubishi Tanabe Pharma Canada, Inc.
    Based in Toronto, Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) with a goal to provide therapies for some of the most difficult-to-treat diseases, including ALS.
  • About Mitsubishi Tanabe Pharma America, Inc.
    Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc.

DolCas Biotech Gains Health Canada Certifications

Retrieved on: 
Monday, October 24, 2022
Monograph, Dietary supplement, Bureau of Oceans and International Environmental and Scientific Affairs, Herbal medicine, Sale, Medicine, Fatigue, Nausea, Appetite, Natural product, Review, Bronchitis, Woman, Homeopathy, Motion sickness, LLC, CAGR, Indigestion, Common, Solubility, Ginger, Statistics Canada, Health Canada, NPN, Trial of the century, Vomiting, Motion, Halls (cough drop), Safety, Minister of Health (Canada), Language, Medicinal plants, Pharmaceutical industry, Mordor

LANDING, NJ., Oct. 24, 2022 /PRNewswire/ -- DolCas Biotech, LLC has attained two Health Canada natural product licenses, one for its concentrated turmeric extract, Curcugen®, and the other for Ginfort®, a powerful ginger extract in powdered format. Produced by Olene Life Sciences, the two ingredient brands are research-backed for clinical efficacy and safety, and are solely distributed by DolCas.

Key Points: 
  • LANDING, NJ., Oct. 24, 2022 /PRNewswire/ --DolCas Biotech, LLC has attained two Health Canada natural product licenses, one for its concentrated turmeric extract , Curcugen, and the other for Ginfort, a powerful ginger extract in powdered format.
  • Products with such licenses have been assessed by Health Canada and found to be safe, effective, and of high quality under their recommended conditions of use.
  • Results of that study are expected to lead DolCas to submit a request to Health Canada to expand the license to include a diversity of claims and doses.
  • "DolCas already is in discussion with several finished product makers and private label companies interested in these brands," adds Dr. Shavon Jackson-Michel, Director of Medical and Scientific Affairs for DolCas Biotech.